SAT0527 Rituximab Prescription Patterns and Efficacy in the Induction Treatment of Anca-Associated Vasculitis in a Belgian Multicentric Cohort

doi 10.1136/annrheumdis-2018-eular.1881

Full Text

Abstract

Available in

Date

June 1, 2018

Authors

F. Vandergheynst

C. von Frenckell

Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports

English

AB0597 Low-Dose Rituximab as Induction Therapy for Japanese Patients With Anca-Associated Vasculitis

English

Anca-Associated Vasculitis

The Journal of scientific articles Health and Education millennium

English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Concurrent Diffuse Alveolar Haemorrhage and Venous Thromboembolism in P-Anca Associated Vasculitis Treated With Rituximab

BMJ Case Reports

English

Genetics of ANCA-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

English

Microscopic Haematuria in ANCA-Associated Vasculitis With Glomerulonephritis During Treatment and Remission

Journal of Vasculitis

English

14. Interstitial Pneumonia in ANCA-associated Vasculitis

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

English

Animal Models of ANCA Associated Vasculitis

Frontiers in Immunology

English